{
  "DOI": "10.1038/s41431-018-0197-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-018-0197-0",
  "alternative-id": [
    "197"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 November 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "18 May 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "22 May 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "14 June 2018"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Professor Burn has a longstanding relationship with Bayer Pharma who have supported the CaPP Cancer Prevention trials. He has received fees for delivering lectures on this topic."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Leenders",
      "given": "Erika K. S. M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Westdorp",
      "given": "Harm",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brüggemann",
      "given": "Roger J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Loeffen",
      "given": "Jan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kratz",
      "given": "Christian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Burn",
      "given": "John",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hoogerbrugge",
      "given": "Nicoline",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jongmans",
      "given": "Marjolijn C. J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        6,
        14
      ]
    ],
    "date-time": "2018-06-14T13:31:59Z",
    "timestamp": 1528983119000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T20:58:08Z",
    "timestamp": 1684616288000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        12
      ]
    ],
    "date-time": "2023-10-12T19:32:15Z",
    "timestamp": 1697139135433
  },
  "is-referenced-by-count": 20,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2018,
        6,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2018,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            6,
            14
          ]
        ],
        "date-time": "2018-06-14T00:00:00Z",
        "timestamp": 1528934400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-018-0197-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-018-0197-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-018-0197-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1417-1423",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2018,
        6,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        6,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1136/jmedgenet-2013-102238",
      "author": "HF Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "journal-title": "J Med Genet",
      "key": "197_CR1",
      "unstructured": "Vasen HF, Ghorbanoghli Z, Bourdeaut F, et al. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet. 2014;51:283–93.",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(11)61049-0",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "2081",
      "journal-title": "Lancet",
      "key": "197_CR2",
      "unstructured": "Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378:2081–7.",
      "volume": "378",
      "year": "2011"
    },
    {
      "DOI": "10.3899/jrheum.090153",
      "author": "J Bourre-Tessier",
      "doi-asserted-by": "publisher",
      "first-page": "1416",
      "journal-title": "J Rheumatol",
      "key": "197_CR3",
      "unstructured": "Bourre-Tessier J, Haraoui B. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol. 2010;37:1416–21.",
      "volume": "37",
      "year": "2010"
    },
    {
      "author": "MD Ricciardone",
      "first-page": "290",
      "journal-title": "Cancer Res",
      "key": "197_CR4",
      "unstructured": "Ricciardone MD, Ozcelik T, Ceher B, et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res. 1999;59:290–3.",
      "volume": "59",
      "year": "1999"
    },
    {
      "author": "Q Wang",
      "first-page": "294",
      "journal-title": "Cancer Res",
      "key": "197_CR5",
      "unstructured": "Wang Q, Lasset C, Desseigne F, Frappaz D, et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 1999;59:294–7.",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1038/ng.3202",
      "author": "A Shlien",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Nat Genet",
      "key": "197_CR6",
      "unstructured": "Shlien A, Campbell BB, de Borja R, et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet. 2015;47:257–62.",
      "volume": "47",
      "year": "2015"
    },
    {
      "author": "W Kohlmann",
      "key": "197_CR7",
      "unstructured": "Kohlmann W, Gruber SB. Lynch Syndrome. In: Pagon RA, et al. Eds. GeneReiews(R). Seattle (WA): University of Washington; 1993.",
      "volume-title": "GeneReiews(R)",
      "year": "1993"
    },
    {
      "DOI": "10.1056/NEJMra012242",
      "author": "HT Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "919",
      "journal-title": "N Engl J Med",
      "key": "197_CR8",
      "unstructured": "Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.",
      "volume": "348",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.ejca.2010.12.024",
      "author": "P Manders",
      "doi-asserted-by": "publisher",
      "first-page": "1407",
      "journal-title": "Eur J Cancer",
      "key": "197_CR9",
      "unstructured": "Manders P, Spruijt L, Kets CM, et al. Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome. Eur J Cancer. 2011;47:1407–13.",
      "volume": "47",
      "year": "2011"
    },
    {
      "DOI": "10.1002/pbc.24019",
      "author": "CA Durno",
      "doi-asserted-by": "publisher",
      "first-page": "652",
      "journal-title": "Pediatr Blood Cancer",
      "key": "197_CR10",
      "unstructured": "Durno CA, Aronson M, Tabori U, Malkin D, Gallinger S, Chan HS. Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred. Pediatr Blood Cancer. 2012;59:652–6.",
      "volume": "59",
      "year": "2012"
    },
    {
      "DOI": "10.1053/j.gastro.2017.02.011",
      "author": "C Durno",
      "doi-asserted-by": "publisher",
      "first-page": "1605",
      "journal-title": "Gastroenterology",
      "key": "197_CR11",
      "unstructured": "Durno C, Boland CR, Cohen S, et al. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017;152:1605–14.",
      "volume": "152",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ejca.2013.12.005",
      "author": "D Bakry",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "journal-title": "Eur J Cancer",
      "key": "197_CR12",
      "unstructured": "Bakry D, Aronson M, Durno C, et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer. 2014;50:987–96.",
      "volume": "50",
      "year": "2014"
    },
    {
      "DOI": "10.1093/annonc/mds113",
      "author": "C Bosetti",
      "doi-asserted-by": "publisher",
      "first-page": "1403",
      "journal-title": "Ann Oncol",
      "key": "197_CR13",
      "unstructured": "Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23:1403–15.",
      "volume": "23",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S1470-2045(09)70035-X",
      "author": "J Cuzick",
      "doi-asserted-by": "publisher",
      "first-page": "501",
      "journal-title": "Lancet Oncol",
      "key": "197_CR14",
      "unstructured": "Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer preention: an international consensus statement. Lancet Oncol. 2009;10:501–7.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.294.1.47",
      "author": "NR Cook",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "journal-title": "JAMA",
      "key": "197_CR15",
      "unstructured": "Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294:47–55.",
      "volume": "294",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa0801297",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "2567",
      "journal-title": "N Engl J Med",
      "key": "197_CR16",
      "unstructured": "Burn J, Bishop DT, Mecklin JP, Macrae F, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359:2567–78.",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(07)60747-8",
      "author": "E Flossmann",
      "doi-asserted-by": "publisher",
      "first-page": "1603",
      "journal-title": "Lancet",
      "key": "197_CR17",
      "unstructured": "Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369:1603–13.",
      "volume": "369",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0140-6736(10)61543-7",
      "author": "PM Rothwell",
      "doi-asserted-by": "publisher",
      "first-page": "1741",
      "journal-title": "Lancet",
      "key": "197_CR18",
      "unstructured": "Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741–50.",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.7326/0003-4819-159-2-201307160-00002",
      "author": "NR Cook",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Ann Intern Med",
      "key": "197_CR19",
      "unstructured": "Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.",
      "volume": "159",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0140-6736(11)61720-0",
      "author": "PM Rothwell",
      "doi-asserted-by": "publisher",
      "first-page": "1602",
      "journal-title": "Lancet",
      "key": "197_CR20",
      "unstructured": "Rothwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602–12.",
      "volume": "379",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0140-6736(12)60209-8",
      "author": "PM Rothwell",
      "doi-asserted-by": "publisher",
      "first-page": "1591",
      "journal-title": "Lancet",
      "key": "197_CR21",
      "unstructured": "Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379:1591–601.",
      "volume": "379",
      "year": "2012"
    },
    {
      "DOI": "10.1097/CCO.0000000000000098",
      "author": "RE Langley",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "journal-title": "Curr Opin Oncol",
      "key": "197_CR22",
      "unstructured": "Langley RE, Rothwell PM. Aspirin in gastrointestinal oncology: new data on an old friend. Curr Opin Oncol. 2014;26:441–7.",
      "volume": "26",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-013-9650-y",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "707",
      "journal-title": "Fam Cancer",
      "key": "197_CR23",
      "unstructured": "Burn J, Mathers JC, Bishop DT. Chemopreention in Lynch syndrome. Fam Cancer. 2013;12:707–18.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1093/bmb/ldw028",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "journal-title": "Br Med Bull",
      "key": "197_CR24",
      "unstructured": "Burn J, Sheth H. The role of aspirin in preventing colorectal cancer. Br Med Bull. 2016;119:17–24.",
      "volume": "119",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMoa067208",
      "author": "AT Chan",
      "doi-asserted-by": "publisher",
      "first-page": "2131",
      "journal-title": "N Engl J Med",
      "key": "197_CR25",
      "unstructured": "Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356:2131–42.",
      "volume": "356",
      "year": "2007"
    },
    {
      "DOI": "10.1126/scitranslmed.3008481",
      "author": "SP Fink",
      "doi-asserted-by": "publisher",
      "first-page": "233re2",
      "journal-title": "Sci Transl Med",
      "key": "197_CR26",
      "unstructured": "Fink SP, Yamauchi M, Nishihara R, et al. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med. 2014;6:233re2.",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.3390/ijms140917279",
      "author": "S Temraz",
      "doi-asserted-by": "publisher",
      "first-page": "17279",
      "journal-title": "Int J Mol Sci",
      "key": "197_CR27",
      "unstructured": "Temraz S, Mukherji D, Shamseddine A. Potential targets for colorectal cancer prevention. Int J Mol Sci. 2013;14:17279–303.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.yexcr.2008.12.010",
      "author": "A Strillacci",
      "doi-asserted-by": "publisher",
      "first-page": "1439",
      "journal-title": "Exp Cell Res",
      "key": "197_CR28",
      "unstructured": "Strillacci A, Griffoni C, Sansone P, et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009;315:1439–47.",
      "volume": "315",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1471-230X-14-1",
      "author": "HM Roelofs",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Gastroenterol",
      "key": "197_CR29",
      "unstructured": "Roelofs HM, Te Morsche RH, an Heumen BW, Nagengast FM, Peters WH. Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol. 2014;14:1.",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jacc.2016.05.083",
      "author": "P Patrignani",
      "doi-asserted-by": "publisher",
      "first-page": "967",
      "journal-title": "J Am Coll Cardiol",
      "key": "197_CR30",
      "unstructured": "Patrignani P, Patrono C. Aspirin and Cancer. J Am Coll Cardiol. 2016;68:967–76.",
      "volume": "68",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2005.09.051",
      "author": "JR Brown",
      "doi-asserted-by": "publisher",
      "first-page": "2840",
      "journal-title": "J Clin Oncol",
      "key": "197_CR31",
      "unstructured": "Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005;23:2840–55.",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1053/j.gastro.2016.07.030",
      "author": "Y Cao",
      "doi-asserted-by": "publisher",
      "first-page": "879",
      "journal-title": "Gastroenterology",
      "key": "197_CR32",
      "unstructured": "Cao Y, Nishihara R, Qian ZR, Song M, et al. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology. 2016;151:879–92.e4.",
      "volume": "151",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2015.08.015",
      "author": "S Zelenay",
      "doi-asserted-by": "publisher",
      "first-page": "1257",
      "journal-title": "Cell",
      "key": "197_CR33",
      "unstructured": "Zelenay S, an der Veen AG, Bottcher JP, et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell. 2015;162:1257–70.",
      "volume": "162",
      "year": "2015"
    },
    {
      "DOI": "10.1007/978-3-642-30331-9_7",
      "author": "PM Rothwell",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Recent Results Cancer Res",
      "key": "197_CR34",
      "unstructured": "Rothwell PM. Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits. Recent Results Cancer Res. 2013;191:121–42.",
      "volume": "191",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12885-017-3757-8",
      "author": "SK Veettil",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Cancer",
      "key": "197_CR35",
      "unstructured": "Veettil SK, Lim KG, Ching SM, Saokaew S, Phisalprapa P, Chaiyakunapruk N. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMC Cancer. 2017;17:763.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1074-7613(03)00177-8",
      "author": "BD Elzey",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Immunity",
      "key": "197_CR36",
      "unstructured": "Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity. 2003;19:9–19.",
      "volume": "19",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.1209182109",
      "author": "G Sitia",
      "doi-asserted-by": "publisher",
      "first-page": "E2165",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "197_CR37",
      "unstructured": "Sitia G, Aiolfi R, Di Lucia P, et al. Antiplatelet therapy prevents hepatocellular carcinoma and improes survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci USA. 2012;109:E2165–72.",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1126/sciimmunol.aai7911",
      "doi-asserted-by": "crossref",
      "key": "197_CR38",
      "unstructured": "Rachidi S, Metelli A, Riesenberg B, et al. Platelets subvert T cell immunity against cancer via GARP-TGFbeta axis. Sci Immunol, 2017;2:1–27."
    },
    {
      "DOI": "10.1073/pnas.95.19.11301",
      "author": "J Ruschoff",
      "doi-asserted-by": "publisher",
      "first-page": "11301",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "197_CR39",
      "unstructured": "Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA. 1998;95:11301–6.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-2562",
      "author": "MA McIlhatton",
      "doi-asserted-by": "publisher",
      "first-page": "10966",
      "journal-title": "Cancer Res",
      "key": "197_CR40",
      "unstructured": "McIlhatton MA, Tyler J, Burkholder S, et al. Nitric oxide-donating aspirin deriaties suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells. Cancer Res. 2007;67:10966–75.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1093/carcin/bgm101",
      "author": "MG Luciani",
      "doi-asserted-by": "publisher",
      "first-page": "2207",
      "journal-title": "Carcinogenesis",
      "key": "197_CR41",
      "unstructured": "Luciani MG, Campregher C, Gasche C. Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through actiation of the checkpoint kinase ATM. Carcinogenesis. 2007;28:2207–17.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00431-014-2485-1",
      "author": "Markus Schmugge",
      "doi-asserted-by": "publisher",
      "first-page": "933",
      "issue": "7",
      "journal-title": "European Journal of Pediatrics",
      "key": "197_CR42",
      "unstructured": "Schmugge M, Speer O, Kroiss S, et al. Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes. Eur J Pediatr, 2015;174:933–41.",
      "volume": "174",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamainternmed.2015.7927",
      "author": "AJ Schoenfeld",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "journal-title": "JAMA Intern Med",
      "key": "197_CR43",
      "unstructured": "Schoenfeld AJ, Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med. 2016;176:172–4.",
      "volume": "176",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamainternmed.2015.7193",
      "author": "B Lazarus",
      "doi-asserted-by": "publisher",
      "first-page": "238",
      "journal-title": "JAMA Intern Med",
      "key": "197_CR44",
      "unstructured": "Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238–46.",
      "volume": "176",
      "year": "2016"
    },
    {
      "DOI": "10.1001/archinternmed.2010.89",
      "author": "MD Howell",
      "doi-asserted-by": "publisher",
      "first-page": "784",
      "journal-title": "Arch Intern Med",
      "key": "197_CR45",
      "unstructured": "Howell MD, Noack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170:784–90.",
      "volume": "170",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJM199905063401801",
      "author": "ED Belay",
      "doi-asserted-by": "publisher",
      "first-page": "1377",
      "journal-title": "N Engl J Med",
      "key": "197_CR46",
      "unstructured": "Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye’s syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340:1377–82.",
      "volume": "340",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0895-4356(00)00366-8",
      "author": "E Autret-Leca",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "J Clin Epidemiol",
      "key": "197_CR47",
      "unstructured": "Autret-Leca E, Jonille-Bera AP, Llau ME, et al. Incidence of Reye’s syndrome in France: a hospital-based surey. J Clin Epidemiol. 2001;54:857–62.",
      "volume": "54",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.1987.03390140075030",
      "author": "ES Hurwitz",
      "doi-asserted-by": "publisher",
      "first-page": "1905",
      "journal-title": "JAMA",
      "key": "197_CR48",
      "unstructured": "Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Serice study of Reye’s syndrome and medications. Report of the main study. JAMA. 1987;257:1905–11.",
      "volume": "257",
      "year": "1987"
    },
    {
      "DOI": "10.1542/peds.77.4.598",
      "author": "MJ Barrett",
      "doi-asserted-by": "crossref",
      "first-page": "598",
      "journal-title": "Pediatrics",
      "key": "197_CR49",
      "unstructured": "Barrett MJ, Hurwitz ES, Schonberger LB, Rogers MF. Changing epidemiology of Reye syndrome in the United States. Pediatrics. 1986;77:598–602.",
      "volume": "77",
      "year": "1986"
    },
    {
      "DOI": "10.1056/NEJM198510033131403",
      "author": "ES Hurwitz",
      "doi-asserted-by": "publisher",
      "first-page": "849",
      "journal-title": "N Engl J Med",
      "key": "197_CR50",
      "unstructured": "Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study on Reye’s syndrome and medications. Report of the pilot phase. N Engl J Med. 1985;313:849–57.",
      "volume": "313",
      "year": "1985"
    },
    {
      "DOI": "10.1097/00000433-199312000-00008",
      "author": "ET Smith Jr.",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "journal-title": "Am J Forensic Med Pathol",
      "key": "197_CR51",
      "unstructured": "Smith ET Jr., Dais GJ. Medium-chain acylcoenzyme—A dehydrogenase deficiency. Not just another Reye syndrome. Am J Forensic Med Pathol. 1993;14:313–8.",
      "volume": "14",
      "year": "1993"
    },
    {
      "DOI": "10.1016/j.pediatrneurol.2008.06.003",
      "author": "JA Gosalakkal",
      "doi-asserted-by": "publisher",
      "first-page": "198",
      "journal-title": "Pediatr Neurol",
      "key": "197_CR52",
      "unstructured": "Gosalakkal JA, Kamoji V. Reye syndrome and reye-like syndrome. Pediatr Neurol. 2008;39:198–200.",
      "volume": "39",
      "year": "2008"
    },
    {
      "DOI": "10.2165/00148581-200709030-00008",
      "author": "K Schror",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Paediatr Drugs",
      "key": "197_CR53",
      "unstructured": "Schror K. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs. 2007;9:195–204.",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0753-3322(00)88500-5",
      "author": "E Gioannucci",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Biomed Pharmacother",
      "key": "197_CR54",
      "unstructured": "Gioannucci E. The prevention of colorectal cancer by aspirin use. Biomed Pharmacother. 1999;53:303–8.",
      "volume": "53",
      "year": "1999"
    },
    {
      "DOI": "10.1136/archdischild-2012-302841",
      "author": "D Eleftheriou",
      "doi-asserted-by": "publisher",
      "first-page": "74",
      "journal-title": "Arch Dis Child",
      "key": "197_CR55",
      "unstructured": "Eleftheriou D, Lein M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014;99:74–83.",
      "volume": "99",
      "year": "2014"
    },
    {
      "DOI": "10.1146/annurev.pharmtox.48.113006.094708",
      "author": "BJ Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Annu Re Pharmacol Toxicol",
      "key": "197_CR56",
      "unstructured": "Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Re Pharmacol Toxicol. 2008;48:303–32.",
      "volume": "48",
      "year": "2008"
    },
    {
      "author": "I Cascorbi",
      "first-page": "546",
      "journal-title": "Dtsch Arztebl Int",
      "key": "197_CR57",
      "unstructured": "Cascorbi I. Drug interactions—principles, examples and clinical consequences. Dtsch Arztebl Int. 2012;109:546–55. quiz 556",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1517/14740338.2014.924924",
      "author": "S Nalamachu",
      "doi-asserted-by": "publisher",
      "first-page": "903",
      "journal-title": "Expert Opin Drug Saf",
      "key": "197_CR58",
      "unstructured": "Nalamachu S, Pergolizzi JV, Raffa RB, Lakkireddy DR, Taylor R Jr. Drug–drug interaction between NSAIDS and low-dose aspirin: a focus on cardioascular and GI toxicity. Expert Opin Drug Saf. 2014;13:903–17.",
      "volume": "13",
      "year": "2014"
    }
  ],
  "reference-count": 58,
  "references-count": 58,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-018-0197-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "26"
}